CSRP3

Quality 0.50 · 1 view · Updated 2 months ago

Protein-coding gene in humans

title: "CSRP3" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public description: "Protein-coding gene in humans" topic_path: "uncategorized" source: "https://en.wikipedia.org/wiki/CSRP3" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Protein-coding gene in humans ::

Cysteine and glycine-rich protein 3 also known as cardiac LIM protein (CLP) or muscle LIM protein (MLP) is a protein that in humans is encoded by the CSRP3 gene.

CSRP3 IS a small 194 amino acid protein, which is specifically expressed in skeletal and cardiac muscle. In rodents, CSRP3 has also been found to be expressed in neurons.

Gene

The CSRP3 gene was discovered in rat in 1994. where it spans a 20kb genomic region, organized in 6 exons. The full length transcript is 0.8kb, while a splice variant, originating from the alternative splicing of exons 3 and 4, was recently identified and designated MLP-b.

Structure

MLP contains two LIM domains (LIM1 and LIM2), each being surrounded by glycine-rich regions, and the two separated by more than 50 residues. LIM domains offer a remarkable ability for protein-protein interactions. Furthermore, MLP carries a nuclear localization signal at amino acid positions 64-69 MLP can be acetylated/deacetylated at the position 69 lysine residue (K69), by acetyltransferase (PCAF) and histone deacetylase 4 (HDAC4), respectively. In myocytes, MLP has the ability to oligomerize, forming dimers, trimers and tetramers, an attribute that impacts its interactions, localization and function.

Protein interactions and localization

MLP has been identified to bind to an increasing list of proteins, exhibiting variable subcellular localization and diverse functional properties. In particular, MLP interacts with proteins at the:

  1. Z-line, including telethonin (T-cap), alpha-actinin (ACTN), cofilin-2 (CFL2), calcineurin, HDAC4, MLP-b as well as to MLP itself;
  2. costameres, where it binds to zyxin, integrin linked kinase (ILK) and beta1-spectrin;
  3. intercalated discs, where it associates with the nebulin-related anchoring protein (NRAP);
  4. nucleus, where it binds to the transcription factors MyoD, myogenin and MRF4. M-line as well as plasma membrane localization of MLP has also been observed, however, the protein associations mediating this subcellular distribution are currently unknown. These diverse localization patterns and binding partners of MLP suggest a multitude of roles relating both to the striated myocyte cytoskeleton and the nucleus. The role of MLP in each of these two cellular compartments appears to be dynamic, with studies demonstrating nucleocytoplasmic shuttling, driven by its nuclear localization signal, over time and under different conditions.

Function

In the nucleus, MLP acts as a positive regulator of myogenesis and promotes myogenic differentiation. Overexpression of MLP enhances myotube differentiation, an effect attributed to the direct association of MLP with muscle specific transcription factors such as MyoD, myogenin and MRF4 and consequently the transcriptional control of fundamental muscle-specific genes. In the cytoplasm, MLP is an important scaffold protein, implicated in various cytoskeletal macromolecular complexes, at the sarcomeric Z-line, the costameres, and the microfilaments. and acts as a scaffold protein promoting the assembly of macromolecular complexes along sarcomeres and actin-based cytoskeleton Moreover, since the Z-line acts as a stretch sensor, MLP is believed to be involved in mechano-signaling processes. Indeed, cardiomyocytes from MLP transgenic or knock-out mouse exhibit defective intrinsic stretch responses, due to selective loss of passive stretch sensing. At the costameres, another region implicated in force transmission, MLP is thought to be contributing in mechanosensing through its interactions with β1 spectrin and zyxin. However, the precise role of MLP at the costameres has not been extensively investigated yet.

At the microfilaments, MLP is implicated in actin remodeling (or actin dynamics) through its interaction with cofilin-2 (CFL2). Binding of MLP to CFL2 enhances the CFL2-dependent F-actin depolymerization,

Additionally, MLP is indirectly related to calcium homeostasis and energy metabolism. Specifically, acetylation of MLP increases the calcium sensitivity of myofilaments and regulates contractility, Furthermore, lack of MLP leads to local loss of mitochondria and energy deficiency.

Animal studies

In rodents, MLP is transiently expressed in amacrine cells of the retina during postnatal development. In the adult nervous system it is expressed upon axonal injury, where it plays an important role during regenerative processes, functioning as an actin cross-linker, thereby facilitating filopodia formation and increasing growth cone motility.

Clinical significance

MLP is directly associated with striated muscle diseases. Mutations in the CSRP3 gene have been detected in patients with dilated cardiomyopathy (DCM) [e.g. G72R and K69R], and hypertrophic cardiomyopathy (HCM) [e.g. L44P, S46R, S54R/E55G, C58G, R64C, Y66C, Q91L, K42/fs165], while the most frequent MLP mutation, W4R, has been found in both of these patient populations. Biochemical and functional studies have been performed for some of these mutant proteins, and reveal aberrant localization and interaction patterns, leading to impaired molecular and cellular functions. For example, the W4R mutation abolishes the MLP/T-cap interaction, leading to mislocalization of T-cap, Z-line instability and severe sarcomeric structural defects. The C58G mutation causes reduced protein stability due to enhanced ubiquitin-dependent proteasome degradation while the K69L mutation, which is within the predicted nuclear localization signal of MLP, abolishes the MLP/α-actinin interaction and causes altered subcellular distribution of the mutant protein, showing predominant perinuclear localization. Alterations in the protein expression levels of MLP, its oligomerization or splicing have also been described in human cardiac and skeletal muscle diseases: both MLP protein levels and oligomerization are down-regulated in human heart failure, Moreover, significant changes in MLP-b protein expression levels, as well as deregulation of the MLP:MLP-b ratio have been detected in limb girdle muscular dystrophy type 2A, Duchenne muscular dystrophy and dermatomyositis patients.

Animal models

Animal models are providing insight into MLP's function in striated muscle. Ablation of Mlp (MLP-/-) in mice affects all striated muscles, although the cardiac phenotype is more severe, leading to alterations in cardiac pressure and volume, aberrant contractility, development of dilated cardiomyopathy with hypertrophy and progressive heart failure. At the histological level there is dramatic disruption of the cardiomyocyte cytoarchitecture at multiple levels, and pronounced fibrosis. Other cellular changes included alterations in intracellular calcium handling, local loss of mitochondria and energy deficiency. Crossing MLP-/- mice with phospholamban (PLN) -/-, or β2-adrenergic receptor (β2-AR) -/-, or angiotensin II type 1a receptor (AT1a) -/-, or β-adrenergic receptor kinase 1 inhibitor (bARK1) -/- mice, as well as overexpressing calcineurin rescued their cardiac function, through a series of only partly understood molecular mechanisms. Conversely crossing MLP-/- mice with β1-adrenergic receptor (β1-AR) -/- mice was lethal, while crossing MLP-/- mice with calcineurin -/- mice, enhanced fibrosis and cardiomyopathy. A gene knockin mouse model harboring the human MLP-W4R mutation developed HCM and heart failure, while ultrastructural analysis of its cardiac tissue revealed myocardial disarray and significant fibrosis, increased nuclear localization of MLP concomitantly with reduced sarcomeric Z-line distribution. Alterations in MLP nucleocytoplasmic shuttling, which are possibly modulated by changes in its oligomerization status, have also been implicated in hypertrophy and heart failure, independently of mutations. Studies in Drosophila revealed that genetic ablation of Mlp84B, the Drosophila homolog of MLP, was associated with pupal lethality and impaired muscle function. Cardiac-specific ablation of Mlp84B caused decreased lifespan, impaired diastolic function and disturbances in cardiac rhythm. Overall, these animal models have provided critical evidence on the functional significance of MLP in striated muscle physiology and pathophysiology.

Notes

References

References

  1. (October 1994). "Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation". Cell.
  2. (2008). "Back to square one: what do we know about the functions of muscle LIM protein in the heart?". Journal of Muscle Research and Cell Motility.
  3. (2001). "Muscle LIM protein in heart failure". Experimental and Clinical Cardiology.
  4. (January 2019). "Muscle LIM Protein Is Expressed in the Injured Adult CNS and Promotes Axon Regeneration". Cell Reports.
  5. (June 1996). "Characterization of a human cardiac gene which encodes for a LIM domain protein and is developmentally expressed in myocardial development". Journal of Molecular and Cellular Cardiology.
  6. (August 1995). "Mapping of a human LIM protein (CLP) to human chromosome 11p15.1 by fluorescence in situ hybridization". Genomics.
  7. (December 2002). "The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy". Cell.
  8. (July 2014). "Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation". The FEBS Journal.
  9. (December 1995). "The cysteine-rich protein family of highly related LIM domain proteins". The Journal of Biological Chemistry.
  10. (July 2011). "MLP (muscle LIM protein) as a stress sensor in the heart". Pflügers Archiv.
  11. (May 2006). "Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin". Molecular Genetics and Metabolism.
  12. (April 2008). "HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity". The Journal of Biological Chemistry.
  13. (January 2007). "Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein". American Journal of Physiology. Heart and Circulatory Physiology.
  14. (October 1997). "Comparison of three members of the cysteine-rich protein family reveals functional conservation and divergent patterns of gene expression". The Journal of Biological Chemistry.
  15. (November 2009). "Muscle LIM protein interacts with cofilin 2 and regulates F-actin dynamics in cardiac and skeletal muscle". Molecular and Cellular Biology.
  16. (June 2000). "Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure". Circulation.
  17. (February 2005). "Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc". Proceedings of the National Academy of Sciences of the United States of America.
  18. (May 2000). "The muscle regulatory and structural protein MLP is a cytoskeletal binding partner of betaI-spectrin". Journal of Cell Science.
  19. (June 2008). "Zebrafish integrin-linked kinase is required in skeletal muscles for strengthening the integrin-ECM adhesion complex". Developmental Biology.
  20. (May 2001). "Alterations at the intercalated disk associated with the absence of muscle LIM protein". The Journal of Cell Biology.
  21. (August 1997). "Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD". Molecular and Cellular Biology.
  22. (March 2010). "A common MLP (muscle LIM protein) variant is associated with cardiomyopathy". Circulation Research.
  23. (October 2009). "Myocyte remodeling in response to hypertrophic stimuli requires nucleocytoplasmic shuttling of muscle LIM protein". Journal of Molecular and Cellular Cardiology.
  24. (June 2013). "Drosophila melanogaster muscle LIM protein and alpha-actinin function together to stabilize muscle cytoarchitecture: a potential role for Mlp84B in actin-crosslinking". Cytoskeleton.
  25. (February 1997). "MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure". Cell.
  26. (March 2011). "Cardiac Z-disc signaling network". The Journal of Biological Chemistry.
  27. (February 2011). "The sarcomeric cytoskeleton: who picks up the strain?". Current Opinion in Cell Biology.
  28. (2009). "The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling". Journal of Muscle Research and Cell Motility.
  29. (June 2011). "Genetics of mechanosensation in the heart". Journal of Cardiovascular Translational Research.
  30. (August 2014). "Human muscle LIM protein dimerizes along the actin cytoskeleton and cross-links actin filaments". Molecular and Cellular Biology.
  31. (December 2000). "Cellular and functional defects in a mouse model of heart failure". American Journal of Physiology. Heart and Circulatory Physiology.
  32. (September 2010). "Hearts of surviving MLP-KO mice show transient changes of intracellular calcium handling". Molecular and Cellular Biochemistry.
  33. (June 2001). "Effects of deletion of muscle LIM protein on myocyte function". American Journal of Physiology. Heart and Circulatory Physiology.
  34. (February 2005). "Regional absence of mitochondria causing energy depletion in the myocardium of muscle LIM protein knockout mice". Cardiovascular Research.
  35. (2014-06-19). "Neuronal expression of muscle LIM protein in postnatal retinae of rodents". PLOS ONE.
  36. (April 2017). "Nociceptive DRG neurons express muscle lim protein upon axonal injury". Scientific Reports.
  37. (July 2015). "Muscle LIM Protein: Master regulator of cardiac and skeletal muscle functions". Gene.
  38. (March 2003). "Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy". Circulation.
  39. (May 2008). "Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy". Clinical and Translational Science.
  40. (2002). "Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis". Molecular Genetics and Metabolism.
  41. (December 2005). "The differential gene expression profiles of proximal and distal muscle groups are altered in pre-pathological dysferlin-deficient mice". Neuromuscular Disorders.
  42. (November 2003). "Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation". Human Molecular Genetics.
  43. (February 2002). "Muscle LIM protein deficiency leads to alterations in passive ventricular mechanics". American Journal of Physiology. Heart and Circulatory Physiology.
  44. (January 2014). "Cardiomyocyte growth and sarcomerogenesis at the intercalated disc". Cellular and Molecular Life Sciences.
  45. (October 2013). "Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice". Journal of Molecular and Cellular Cardiology.
  46. (June 2010). "Calcineurin protects the heart in a murine model of dilated cardiomyopathy". Journal of Molecular and Cellular Cardiology.
  47. (October 1999). "Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy". Cell.
  48. (June 1998). "Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice". Proceedings of the National Academy of Sciences of the United States of America.
  49. (December 2007). "Angiotensin II type 1a receptor signals are involved in the progression of heart failure in MLP-deficient mice". Circulation Journal.
  50. (August 2011). "Deletion of Drosophila muscle LIM protein decreases flight muscle stiffness and power generation". American Journal of Physiology. Cell Physiology.
  51. (January 2008). "The Drosophila muscle LIM protein, Mlp84B, is essential for cardiac function". The Journal of Experimental Biology.

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::